Navigation Links
Align Technology Executive to Present at Upcoming Financial Conferences
Date:9/4/2007

SANTA CLARA, Calif., Sept. 4 /PRNewswire-FirstCall/ -- Align Technology, Inc. (Nasdaq: ALGN), the inventor of Invisalign(R), a proprietary method of straightening teeth without wires and brackets, announced today that Thomas M. Prescott, President and Chief Executive Officer of Align Technology, is scheduled to speak at two upcoming financial conferences in New York. All presentations, as noted below, will be web cast live via the Internet on Align's web site at http://investor.aligntech.com. An archived replay will remain on the web site for one month. Details follow:

Conference: Bear Stearns 20th Annual Healthcare Conference

Date: Tuesday, September 11, 2007

Presentation: 11:00 to 11:25 a.m. Eastern Time

Breakout: 11:30 to 11:55 a.m. Eastern Time

Conference: UBS Global Life Sciences Conference

Date: Tuesday, September 25, 2007

Presentation: 11:00 to 11:25 a.m. Eastern Time

Breakout: 11:30 to 11:55 a.m. Eastern Time

About Align Technology, Inc.

Align Technology designs, manufactures and markets Invisalign, a proprietary method for treating malocclusion, or the misalignment of teeth. Invisalign corrects malocclusion using a series of clear, nearly invisible, removable appliances that gently move teeth to a desired final position. Because it does not rely on the use of metal or ceramic brackets and wires, Invisalign significantly reduces the aesthetic and other limitations associated with braces. Invisalign is appropriate for treating adults and older teens. Align Technology was founded in March 1997 and received FDA clearance to market Invisalign in 1998.

To learn more about Invisalign or to fin
'/>"/>

SOURCE Align Technology, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. A better test than cytology for Urinary Malignancy
2. Blood test developed for malignant hyperthermia
3. Malignant Mesothelioma – A New Genetic Revelatio
4. Malignant Mesothelioma – A New Genetic Revelation
5. Malignant virus in polio vaccine combined to Cancer
6. Indian Researcher Discovers Reason For Malignancy of Skin Cancer
7. Experimental Therapy Effective Against Malignant Melanoma in Horses
8. Seattle, a hub for malignant melanoma? Time To Get Sunwise!
9. Protein Involved In Embryo Formation Found In Malignant Cells
10. When Her Lot is maligned by HER-2, Staying Abreast is Imperative
11. Novel Suicide Gene Therapy Used to Treat Malignant Brain Tumors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2008)...Aug. 29 /PRNewswire-USNewswire/ -- The Holiday,Sta...aul suburb of Eagan,will reduce the price of E85 b...m 11 a.m. until 1 p.m. The promotion is timed to o...d the fleet of flexible fuel vehicles,General Moto... There is a,15 gallon limit per flexible fuel vehi...
(Date:8/29/2008)... caused chromosomal change that raises odds for ma...9 (HealthDay News) -- Some Japanese survivors of t...d Nagasaki experienced key genetic changes that ma...er, new research indicates. , Papillary thyroid...genetic mutation involving the so-called BRAF gene...
(Date:8/29/2008)..., Aug. 29 /PRNewswire/ -- In response to recent ne...ic wasting disease (CWD),members of the deer farm..., With hunting season fast approaching, the tragi...r on a Kent County farm understandably has,created...er farmers across,the great state of Michigan. The...
(Date:8/29/2008)...Opens Market to More Than 30 European Countries, ...nc. announced today,that it has successfully compl... and the Medical Device Directive (for most Europe...oveted CE Mark -- or Conformite Europeene Mark,-- ... expands Hoana,s,patient safety reach to include m...
Breaking Medicine News(10 mins):Health News:An 'Unconventional' Fuel at an Unbelievable Price: Minnesota Station Cuts Cost of E85 by $1 Per Gallon 2Health News:Some Hiroshima Survivors at Thyroid Cancer Risk 2Health News:Some Hiroshima Survivors at Thyroid Cancer Risk 3Health News:Deer Farm Industry in Michigan Issues Statement on the Recent Chronic Wasting Disease Case Identified on a Kent County Deer Farm 2Health News:Hoana Medical Acquires CE Mark to Expand Patient Safety Technology to European Market 2Health News:Hoana Medical Acquires CE Mark to Expand Patient Safety Technology to European Market 3Health News:Hoana Medical Acquires CE Mark to Expand Patient Safety Technology to European Market 4
...the Journal of the American Medical Association's ...erly women who have not received// up to the mark ...in delayed diagnoses, as compared to the younger l...te Medical Center of Orange County, Calif., and co...
...ssage and if sound bytes from the Food and Drink F...pular brands// have been doing their bit to reduce...e FDF books speak about a whopping ?1.5 billion wo... the fat portion cut-off for the good health of po...
...h causes most genital warts, is also held responsi...istics claim that over 2,800 women are diagnosed w...to it each year in the UK. A vaccine named Gardsil...ved effective in protecting humans from the most d...
...vidence to show that a couple of weeks of regular ...the risk of onset of pneumonia// and other lung di... in cardiac patients. The study conducted at Univ...erlands was done on 279 heart patients requiring ...
Other Medicine News:
(Date:8/26/2008)...- Cambridge Research &,Instrumentatio...(TM) EX In,Vivo Imaging System. The new system inc...nd becomes the entry-level instrument of choice fo...www.newscom.com/cgi-bin/prnh/20080826/NETU054 ), ...ent of CRi,s unique,solid-state tunable optics tha...
(Date:8/25/2008)...tion and Treatment Strategies--, PHILADELPHIA, Au...iscovered gene mutations that are the main cause o...uroblastoma. In addition, the researchers found,th...igh-risk forms of,non-inherited neuroblastoma, the...y enables us to offer the first genetic tests to f...
(Date:8/22/2008)...Trial Sponsored by Medical Research Council, LEXI...devus,Pharmaceuticals, Inc. (Nasdaq: IDEV ) annou...l MDP 301, a Phase III clinical trial of PRO 2000,...he prevention of HIV and other,sexually transmitte...,Kingdom,s Medical Research Council (MRC) and cond...
(Date:8/21/2008)... /PRNewswire-USNewswire/ -- Dangerous disease,ofte...he lab. To remedy,that, researchers at Kansas Stat...ime from days down to hours., Sanjeev Narayanan, ...icrobiologist, both in the department of diagnosti... DNA spotted microarray to seek out the,specific g...
Breaking Medicine Technology:CRi Announces New Maestro(TM) EX In Vivo Imaging System with Improved Performance and an Affordable Price 2Gene That Causes Childhood Cancer Neuroblastoma Is Found 2Gene That Causes Childhood Cancer Neuroblastoma Is Found 3Gene That Causes Childhood Cancer Neuroblastoma Is Found 4Indevus Pharmaceuticals Announces Completion of Enrollment in Phase III Trial of PRO 2000 2Indevus Pharmaceuticals Announces Completion of Enrollment in Phase III Trial of PRO 2000 3Indevus Pharmaceuticals Announces Completion of Enrollment in Phase III Trial of PRO 2000 4Indevus Pharmaceuticals Announces Completion of Enrollment in Phase III Trial of PRO 2000 5Rapid Test for Pathogens Developed By K-State Researchers Could Be Used to Detect Diseases Used By Bioterrorists 2Cellular decision on the computer 23898 1Cellular decision on the computer 23898 2Huntingtons disease 3A catching it early 4006 1New studies predict record land grab as demand soars for new sources of food energy and wood fiber 4003 1New studies predict record land grab as demand soars for new sources of food energy and wood fiber 4003 2New studies predict record land grab as demand soars for new sources of food energy and wood fiber 4003 3New studies predict record land grab as demand soars for new sources of food energy and wood fiber 4003 4New studies predict record land grab as demand soars for new sources of food energy and wood fiber 4003 5New studies predict record land grab as demand soars for new sources of food energy and wood fiber 4003 6Aspire IRB Announces the Launch of an Automated Web Portal System 23895 1Aspire IRB Announces the Launch of an Automated Web Portal System 23895 2
...ine-urea derivative compound series,show highly se...r,cancer treatment, QUEBEC, April 16, 2007 /PRNews..., pure play biopharmaceutical company focused on,e...abstract,outlining first in vitro data on its pyri...I3K inhibition, at the American,Association for Ca...
...er Patients With Improved Potential to,Battle Thei...swire/ -- Insert,Therapeutics, Inc., a majority-ow...nnounced today its novel delivery system,called Cy...ion at,the 2007 American Association for Cancer Re...poster includes new research findings,on a promisi...
Other Medicine Technology:AEterna Zentaris Discloses First In Vitro Data for its PI3K,Inhibitors at the AACR Annual Meeting in Los Angeles 2AEterna Zentaris Discloses First In Vitro Data for its PI3K,Inhibitors at the AACR Annual Meeting in Los Angeles 3Poster on Cyclosert Drug Delivery Presented at AACR Meeting 2Poster on Cyclosert Drug Delivery Presented at AACR Meeting 3Poster on Cyclosert Drug Delivery Presented at AACR Meeting 4
...ce the finest surgical-quality loupes available a...for innovative optical design, combining superior ...g optimum performance with maximum comfort, SheerV...essionals worldwide. All SheerVision loupes come c...
...ce the finest surgical-quality loupes available a...for innovative optical design, combining superior ... optimum performance with maximum comfort, SheerVi...ssionals worldwide. Make both a professional and a...
...ce the finest surgical-quality loupes available a...for innovative optical design, combining superior ... optimum performance with maximum comfort, SheerVi...ssionals worldwide. All SheerVision loupes come co...
...ion manufactures its signature line of award-winni...ightweight, yet durable titanium frame. These next...on razor-sharp clarity, an ultra-lightweight desi...-fog, and scratch resistance. With SheerVision fl...
Medicine Products: